These results were consistent with our previous observations that ARID1A- CRC cell lines are more sensitive to ATR inhibitors and indicated that the radiosensitizing effect after ATRi treatment mainly relied on the ARID1A status of the cell lines. Here, ATR is linked to colorectal carcinoma.